BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | – | 28 | +86.7% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 15 | -70.0% | 0.00% | – |
| Q1 2023 | $2 | +100.0% | 50 | +42.9% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 35 | -23.9% | 0.00% | – |
| Q3 2022 | $2,000 | -99.8% | 46 | -99.7% | 0.00% | -100.0% |
| Q2 2022 | $1,034,000 | -92.7% | 16,105 | -91.2% | 0.00% | -93.8% |
| Q1 2022 | $14,123,000 | +515.1% | 182,147 | +580.7% | 0.02% | +700.0% |
| Q4 2021 | $2,296,000 | -98.7% | 26,760 | -98.8% | 0.00% | -99.0% |
| Q3 2021 | $172,926,000 | -29.7% | 2,150,039 | -29.6% | 0.20% | -29.3% |
| Q2 2021 | $245,907,000 | -27.2% | 3,054,757 | -23.7% | 0.28% | -32.5% |
| Q1 2021 | $337,877,000 | +2.9% | 4,006,141 | -2.1% | 0.41% | -1.4% |
| Q4 2020 | $328,509,000 | -5.4% | 4,094,094 | -5.2% | 0.42% | -15.0% |
| Q3 2020 | $347,423,000 | -11.9% | 4,320,117 | -5.7% | 0.49% | -19.5% |
| Q2 2020 | $394,293,000 | -4.1% | 4,579,491 | -9.6% | 0.61% | -19.6% |
| Q1 2020 | $411,274,000 | -27.3% | 5,065,582 | -25.2% | 0.75% | -6.7% |
| Q4 2019 | $565,995,000 | -6.4% | 6,768,671 | -2.1% | 0.81% | -18.6% |
| Q3 2019 | $604,496,000 | +5.3% | 6,910,907 | -1.4% | 0.99% | +6.7% |
| Q2 2019 | $574,205,000 | +35.2% | 7,011,056 | +34.2% | 0.93% | +34.0% |
| Q1 2019 | $424,651,000 | +43.9% | 5,222,634 | +16.5% | 0.70% | +28.0% |
| Q4 2018 | $295,112,000 | +120353.9% | 4,483,639 | +140673.6% | 0.54% | – |
| Q3 2018 | $245,000 | -86.7% | 3,185 | -87.3% | 0.00% | -100.0% |
| Q2 2018 | $1,847,000 | -69.3% | 25,016 | -73.0% | 0.00% | -70.0% |
| Q1 2018 | $6,014,000 | -12.1% | 92,481 | -12.6% | 0.01% | -16.7% |
| Q4 2017 | $6,840,000 | +111.3% | 105,829 | +105.1% | 0.01% | +100.0% |
| Q3 2017 | $3,237,000 | +3.8% | 51,595 | +0.1% | 0.01% | 0.0% |
| Q2 2017 | $3,120,000 | +572.4% | 51,541 | +475.3% | 0.01% | +500.0% |
| Q1 2017 | $464,000 | -97.7% | 8,959 | -98.1% | 0.00% | -97.6% |
| Q4 2016 | $20,433,000 | -12.2% | 460,836 | -5.7% | 0.04% | -8.7% |
| Q3 2016 | $23,261,000 | +2.6% | 488,695 | -2.5% | 0.05% | -4.2% |
| Q2 2016 | $22,668,000 | +139.8% | 501,307 | +117.9% | 0.05% | +128.6% |
| Q1 2016 | $9,452,000 | +1074.2% | 230,112 | +989.7% | 0.02% | +950.0% |
| Q4 2015 | $805,000 | +63.6% | 21,117 | +40.9% | 0.00% | +100.0% |
| Q3 2015 | $492,000 | -99.9% | 14,982 | -99.8% | 0.00% | -99.9% |
| Q2 2015 | $456,794,000 | +0.1% | 6,532,181 | -1.9% | 0.96% | -2.5% |
| Q1 2015 | $456,198,000 | -4.3% | 6,659,850 | +2.4% | 0.98% | -3.4% |
| Q4 2014 | $476,802,000 | +15.8% | 6,505,704 | +13.4% | 1.02% | +15.2% |
| Q3 2014 | $411,685,000 | +10.1% | 5,736,182 | +10.9% | 0.88% | +13.2% |
| Q2 2014 | $373,856,000 | -4.0% | 5,170,918 | -2.3% | 0.78% | -10.2% |
| Q1 2014 | $389,492,000 | +3.3% | 5,293,477 | -2.3% | 0.87% | +3.9% |
| Q4 2013 | $376,909,000 | -9.6% | 5,419,272 | -14.6% | 0.84% | -15.4% |
| Q3 2013 | $416,828,000 | +20.4% | 6,345,402 | +27.0% | 0.99% | +20.6% |
| Q2 2013 | $346,124,000 | – | 4,996,760 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |